期刊文献+

PRISMA声明应用现状调查 被引量:11

Application of PRISMA Statement: A Status-quo Survey
原文传递
导出
摘要 目的了解PRISMA声明的应用情况。方法计算机检索PubMed、EMbase、The Cochrane Library(2013,第10期)、CBM、WanFang Data和CNKI数据库,收集应用PRISMA声明的相关文献,检索时限均为从2009年至2013年。由2位研究者按照纳入与排除标准筛选文献并提取资料,然后采用EXCEL软件进行文献计量分析。结果最终纳入175篇文献,其中会议摘要26篇,全文149篇。对149篇全文的文献计量分析结果显示:这些文献发表在118种期刊上,而PRISMA官网公布的支持期刊有176种。按研究类型分类,系统评价/Meta分析111篇(既用于制作,也用于报告),系统评价再评价20篇(用于报告质量评价),PRISMA声明解读文献7篇,其他11篇。131篇用于系统评价/Meta分析以及系统评价再评价的文献中,西医领域占77.8%,其次为公共卫生(8.4%)、中医(4.6%)。结论 PRISMA声明的应用尚处于起步阶段,并且主要局限在西医领域,对其重视和认识还很不够,应加强对其进行解读和推广。 Objective To get known of the application of Preferred Items of Systematic Review and Meta Analysis (PRISMA). Methods We searched PubMed, EMbase, Ihe Cochrane Library (Issue 10, 2013), CBM, WanFang Data and CNKI, to collect relevant literature about the application of PRISMA during 2009-2013. Two reviewers independently screened literature according to the inclusion and exclusion criteria, extracted data, and then bibliometric analysis was performed using Excel software. Results We finally included 175 papers, including 26 conference abstracts and 149 full texts. The results of bibliometric analysis of full texts showed that, they were published in 118 journals, and PRISMA of- ficial website announced that 176 journals endorsed the application of PRISMA. According to study type, there were 111 systematic reviews and meta-analyses (SRs/MAs) for development and reporting, 20 overviews of SRs for reporting qual- ity assessments, 7 versions of PRISMA interpretation, and 11 articles of other kinds. In 131 SRs/MAs as well as overviews, the studies about western medicine accounted for 77.8%, followed by public health (8.4%), and traditional Chinese medi- cine (4.6%). Conclusion The application of PRISMA statement is still at the first phase and mainly confined to the field of western medicine, which needs more attention and understanding. Thus, it's necessary to interpret and disseminate the PRISMA statement.
出处 《中国循证医学杂志》 CSCD 2014年第9期1160-1164,共5页 Chinese Journal of Evidence-based Medicine
基金 国家自然科学基金面上项目(编号:81373882)
关键词 PRISMA声明 报告指南 系统评价 META分析 PRISMA statement Reporting guideline Systematic review Meta-analysis
  • 相关文献

参考文献18

  • 1Furberg CD. Effect of antiarrhythmic drugs on mortality after myo-cardial infarction. Am J Cardiol, 1983, 52(6): C32-C36.
  • 2Moher D, Tetzlaff J, Tricco AC, et al. Epidemiology and reportingcharacteristics of systematic reviews. PLoS Med, 2007,4(3): e78.
  • 3Bastian H, Glasziou P, Chalmers I. Seventy-five trials and elevensystematic reviews a day: how will we ever keep up? PLoS Med, 2010,7(9): e1000326.
  • 4The PRISMA Group. History. [2014-2-26]. Available at: http://www.prisma-statement.org/history.htni.
  • 5Mulrow CD. The medical review article: State of the science. AnnIntern Med, 1987,106(3): 485-488.
  • 6Sacks HS, Berrier J, Reitman D, et al. Meta-analysis of randomizedcontrolled trials. New Engl J Med, 1987, 316 (8): 450-455.
  • 7Moher D, Cook D J, Eastwood S, et al. Improving the quality ofreports of meta-analyses of randomised controlled trials: the QUO-ROM statement. The Lancet, 1999, 354(9193): 1896-1900.
  • 8尹森林,刘雪梅,何林,李幼平.对系统评价/Meta分析报告规范的系统评价[J].中国循证医学杂志,2011,11(8):971-977. 被引量:29
  • 9The PRISMA Group. Welcome to the PRISMA Statement website.[2014-2-26]. Available at: http://www.prisma-statement.org/index.htm.
  • 10The PRISMA Group. Conceptual Issues in the Evolution fromQUOROM to PRISMA. 2014-2-26. Available at: http://www.prisma-statement.org/conceptual.htm.

二级参考文献118

共引文献303

同被引文献175

引证文献11

二级引证文献78

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部